Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2004;90:7-8; doi:10.1136/heart.90.1.7
Copyright © 2004 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2004;90:7-8
© 2004 by BMJ Publishing Group & British Cardiac Society

EDITORIAL

From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy

S L Van Driest1, B J Maron2, M J Ackerman1,*

1 Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
2 The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA

Correspondence to:
Correspondence to:
Michael J Ackerman
MD, PhD, Sudden Death Genomics Laboratory, Mayo Clinic College of Medicine, 200 First Street SW, Guggenheim 501, Rochester, MN 55905, USA; ackerman.michael{at}mayo.edu

ABSTRACT

The genetic causes of hypertrophic cardiomyopathy are diverse and thus present challenges in the development of genetic tests to identify patients at risk

Keywords: hypertrophic cardiomyopathy; genetics; ß myosin heavy chain gene


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Bos, J. M., Towbin, J. A., Ackerman, M. J. (2009). Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy.. J Am Coll Cardiol 54: 201-211 [Abstract] [Full Text]  
  • Revera, M., van der Merwe, L., Heradien, M., Goosen, A., Corfield, V. A., Brink, P. A., Moolman-Smook, J. C. (2008). Troponin T and {beta}-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy. Cardiovasc Res 77: 687-694 [Abstract] [Full Text]  
  • De Backer, J., Matthys, D., Gillebert, T.C., De Paepe, A., De Sutter, J. (2005). The use of Tissue Doppler Imaging for the assessment of changes in myocardial structure and function in inherited cardiomyopathies. Eur J Echocardiogr 6: 243-250 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Show me all >>